Cilostazol (Q33539485)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cilostazol	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

Cilostazol. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Alexander Markham

2

object named as

A Markham

0 references

author name string

E M Sorkin

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A Markham

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

63-71; discussion 72-3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cilostazol, a new antithrombotic drug, on cerebral circulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cilostazol, a cAMP Phosphodiesterase Inhibitor, Attenuates the Production of Monocyte Chemoattractant protein-1 in Response to Tumor Necrosis Factor-α in Vascular Endothelial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Multiple‐Dose Oral Cilostazol in Middle‐Age and Elderly Men and Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cilostazol on platelet aggregation and experimental thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhdbitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation on combined administration of oral prostacyclin analogue beraprost and phosphodiesterase inhibitor cilostazol

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of cilostazol. Safety evaluation at increasing single doses in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10069409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-199914010-00005

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

release_733myzeoxbforgh34527qyzjj4

1 reference

https://api.fatcat.wiki/v0/release/733myzeoxbforgh34527qyzjj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33539485&oldid=2195468000"